₅Gary T Kinasewitz

Summary for 2003 [at-glance overview of Gary T Kinasewitz work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Gary T Kinasewitz. According to available data, in 2003 Gary T Kinasewitz published at least 5 articles. This work was completed in collaboration with several authors including Dhainaut, Jean-François and Levy, Howard. Many other authors have collaborated with Gary T Kinasewitz as well. There is at least one grant awarded to support this work.

Gary T Kinasewitz has rank 23 when compared to all other authors using the keyword Protein C. Analysis of the article abstracts and the titles suggests that Gary T Kinasewitz professional interests are focused around "drotrecogin alfa activated", "patients severe sepsis" and "neutrophil cd10 expression". These might also be referred to as "drotrecogin alfa", "alfa activated" or "severe sepsis". Statistical analysis shows that Gary T Kinasewitz's writing is likely to contains terms "activated", "patients", "drotrecogin", "alfa", "sepsis" and "severe".

Unfortunately, there is not enough information to establish Gary T Kinasewitz affiliation. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Gary T Kinasewitz]

Do you know Gary T Kinasewitz who matches the profile above? Click the photo and let us know!

Alternative names (0) [other authors with names similar to Gary T Kinasewitz]

none

Year 2003 Charts [Gary T Kinasewitz frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Gary T Kinasewitz publication and funding history for the range of years]

Emails (4) [email addresses extracted from Gary T Kinasewitz affiliations]

hidden to prevent spam, click here to reveal

Gary T Kinasewitz Coauthors (21) [all coauthors with the number of joint publications]

explore visually

Other [context-specific ads]

Affiliations (5) [condensed summary of the Gary T Kinasewitz affiliations, the leading number and the color conveys importance]

₁Service de Reanimation Medicale, Centre Hospitalo-Universitaire Cochin Port-Royal, AP-HP, Paris V University, Paris, France.
₁Department of Intensive Care, Cochin Hospital, Cochin Institute, Cochin Port-Royal Medical School, Paris V University, France.
₁Free Radical Biology and Aging Research, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104, USA.
₁Brown University School of Medicine, Providence, RI, USA.
₁Department of Medicine, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma, USA.

Key Opinion Leader In [Gary T Kinasewitz is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₂₃Protein C | ₆₂Sepsis | ₁₇₁Inflammation | ₅₄₉Recombinant Proteins

Keywords (32) [keywords assigned to Gary T Kinasewitz articles by PubMed, the leading number and the color conveys importance]

₅Humans | ₃Recombinant Proteins | ₃Sepsis | ₃Protein C | ₃Inflammation | ₂Survival Analysis | ₂Blood Coagulation | ₂Biological Markers | ₂Dose-Response Relationship, Drug | ₂Anti-Infective Agents | ₂Double-Blind Method | ₁Confidence Intervals | ₁Follow-Up Studies | ₁Fungi | ₁Paracentesis | ₁Thoracoscopy | ₁Gram-Positive Bacterial Infections | ₁Lipopolysaccharides | ₁Drug Administration Schedule | ₁Escherichia coli | ₁Gram-Negative Bacterial Infections | ₁Plasminogen Activator Inhibitor 1 | ₁APACHE | ₁Intensive Care Units | ₁Severity of Illness Index | ₁Animals | ₁Anti-Bacterial Agents | ₁Neprilysin | ₁Stem Cells | ₁Radionuclide Imaging | ₁Papio | ₁Time Factors

Gary T Kinasewitz Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Gary T Kinasewitz might be a good expert witness on these terms]

₁₉activated | ₁₈patients | ₁₇drotrecogin | ₁₇alfa | ₁₄sepsis | ₁₃severe | ₁₁cd10 | ₈expression | ₈reduced | ₇results | ₇neutrophil | ₇prowess | ₆response | ₆observed | ₆pleural | ₆treatment | ₅hydrothorax | ₅significant | ₅human | ₅challenge | ₄underlying | ₄inflammatory | ₄effect | ₄can | ₄therapy | ₄data | ₄levels | ₄fluid | ₄placebo | ₃confidence | ₃interval | ₃patient
₁₇drotrecogin alfa | ₁₇alfa activated | ₁₃severe sepsis | ₈patients severe | ₆cd10 expression | ₅neutrophil cd10 | ₅effects drotrecogin | ₄hepatic hydrothorax | ₄evaluation committee | ₄clinical evaluation | ₄prowess trial | ₃significant underlying | ₃confidence interval | ₃sepsis prowess | ₃change baseline | ₃systemic biomarkers | ₂reduces host | ₂recombinant human | ₂activated protein | ₂human activated | ₂review data | ₂effect significant | ₂neutrophil surface | ₂imputation method | ₂reduced neutrophil | ₂underlying disorders | ₂inflammatory challenge | ₂centers enrolled | ₂preinjection levels | ₂baseline analyses | ₂expression nonhuman | ₂resolved preinjection
₁₇drotrecogin alfa activated | ₈patients severe sepsis | ₅neutrophil cd10 expression | ₅effects drotrecogin alfa | ₄clinical evaluation committee | ₃severe sepsis prowess | ₂patients medical centers | ₂nonhuman primates humans | ₂severe sepsis patients | ₂primates humans vivo | ₂integrated review data | ₂coagulopathy response patients | ₂reduces host coagulopathy | ₂protein reduces host | ₂medical centers enrolled | ₂expression nonhuman primates | ₂humans vivo challenge | ₂effect significant locf | ₂confidence interval 69-0 | ₂activated recombinant human | ₂blinded critical integrated | ₂benefit associated drotrecogin | ₂response patients severe | ₂resolved preinjection levels | ₂recombinant human activated | ₂centers enrolled prowess | ₂significant underlying disorders | ₂percent change baseline | ₂significant locf imputation | ₂activated protein reduces | ₂reduced neutrophil cd10 | ₂alfa activated recombinant

Reader's Comments (0) [comments posted by readers of Gary T Kinasewitz profile]